$NOTE
FiscalNote Holdings, Inc. Stock $note

$note Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000095017024031826 Filed on March 15, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$34.27M	$132.6M
YoY Change	8.95%	16.6%
Cost Of Revenue	$5.982M	$24.39M
YoY Change	0.94%	6.78%
Gross Profit	$28.28M	$108.3M
YoY Change	10.81%	19.06%
Gross Profit Margin	82.54%	81.61%
Selling, General & Admin	$31.57M	$111.3M
YoY Change	-6.97%	-7.64%
% of Gross Profit	111.63%	102.79%
Research & Development	$4.016M	$18.19M
YoY Change	-24.2%	-12.3%
% of Gross Profit	14.2%	16.8%
Depreciation & Amortization	$8.642M	$1.348M
YoY Change	59.77%	8.89%
% of Gross Profit	30.56%	1.25%
Operating Expenses	$43.89M	$230.4M
YoY Change	-0.92%	14.08%
Operating Profit	-$15.61M	-$97.74M
YoY Change	-16.88%	10.83%
Interest Expense	-$10.95M	-$13.96M
YoY Change	-7.53%	-83.18%
% of Operating Profit
Other Income/Expense, Net	$2.082M	-$68.00K
YoY Change	643.57%	-93.49%
Pretax Income	-$50.71M	-$115.2M
YoY Change	18.03%	-47.98%
Income Tax	$42.00K	$223.0K
% Of Pretax Income
Net Earnings	-$50.75M	-$115.5M
YoY Change	19.28%	-47.1%
Net Earnings / Revenue	-148.1%	-87.05%
Basic Earnings Per Share		-$0.88
Diluted Earnings Per Share	-$0.39	-$0.88
COMMON SHARES
Basic Shares Outstanding		131.4M
Diluted Shares Outstanding		131.4M

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.59M	$23.59M
YoY Change	-60.94%	-60.94%
Cash & Equivalents	$16.45M	$16.45M
Short-Term Investments	$7.134M	$7.134M
Other Short-Term Assets	$2.521M	$9.289M
YoY Change	-8.79%	-13.25%
Inventory
Prepaid Expenses	$2.593M
Receivables	$16.93M	$16.93M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$49.81M	$49.81M
YoY Change	-42.09%	-42.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.141M	$23.92M
YoY Change	-16.16%	-15.56%
Goodwill	$187.7M
YoY Change	-3.43%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$633.0K	$4.890M
YoY Change	43.21%	10.68%
Total Long-Term Assets	$320.8M	$320.8M
YoY Change	-7.6%	-7.6%
TOTAL ASSETS
Total Short-Term Assets	$49.81M	$49.81M
Total Long-Term Assets	$320.8M	$320.8M
Total Assets	$370.6M	$370.6M
YoY Change	-14.45%	-14.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.91M	$12.91M
YoY Change	-6.04%	-6.04%
Accrued Expenses	$3.066M	$3.066M
YoY Change	-54.3%	-54.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$105.0K	$105.0K
YoY Change	54.41%	54.41%
Total Short-Term Liabilities	$65.65M	$65.65M
YoY Change	5.7%	5.7%
LONG-TERM LIABILITIES
Long-Term Debt	$222.3M	$222.3M
YoY Change	37.25%	37.25%
Other Long-Term Liabilities	$5.166M	$36.96M
YoY Change	-62.72%	-41.94%
Total Long-Term Liabilities	$227.5M	$259.3M
YoY Change	29.37%	14.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$65.65M	$65.65M
Total Long-Term Liabilities	$227.5M	$259.3M
Total Liabilities	$327.1M	$327.1M
YoY Change	13.39%	13.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$816.4M
YoY Change	16.51%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.46M	$43.46M
YoY Change
Total Liabilities & Shareholders Equity	$370.6M	$370.6M
YoY Change	-14.45%	-14.45%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$50.75M	-$115.5M
YoY Change	19.28%	-47.1%
Depreciation, Depletion And Amortization	$8.642M	$1.348M
YoY Change	59.77%	8.89%
Cash From Operating Activities	-$3.554M	-$35.49M
YoY Change	-76.5%	-51.13%
INVESTING ACTIVITIES
Capital Expenditures	$1.981M	$7.938M
YoY Change	-21.01%	-30.17%
Acquisitions		$5.010M
YoY Change		-545.33%
Other Investing Activities		-$12.38M
YoY Change		-1200.36%
Cash From Investing Activities	-$1.981M	-$20.32M
YoY Change	-21.01%	98.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$107.0K
YoY Change		-99.94%
Cash From Financing Activities	5.507M	12.08M
YoY Change	36613.33%	-89.17%
NET CHANGE
Cash From Operating Activities	-3.554M	-35.49M
Cash From Investing Activities	-1.981M	-20.32M
Cash From Financing Activities	5.507M	12.08M
Net Change In Cash	-28.00K	-43.92M
YoY Change	-99.84%	-255.68%
FREE CASH FLOW
Cash From Operating Activities	-$3.554M	-$35.49M
Capital Expenditures	$1.981M	$7.938M
Free Cash Flow	-$5.535M	-$43.43M
YoY Change	-68.61%	-48.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001823466
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FinanceLeaseLiability
CY2022Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FinanceLeaseLiability
CY2023Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FinanceLeaseLiability
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1	2024
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1	2025
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1	2026
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1	2027
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1	2028
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.fiscalnote.com/20231231#ChangeInFairValueOfFinancialInstruments
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.fiscalnote.com/20231231#ChangeInFairValueOfFinancialInstruments
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-396972
CY2023	dei	Entity Registrant Name EntityRegistrantName	FISCALNOTE HOLDINGS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-3772307
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1201 Pennsylvania Avenue NW, 6th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Washington, D.C.
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20004
CY2023	dei	City Area Code CityAreaCode	202
CY2023	dei	Local Phone Number LocalPhoneNumber	793-5300
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	290009098
CY2023	dei	Auditor Name AuditorName	RSM US LLP
CY2023	dei	Auditor Location AuditorLocation	McLean, Virginia
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16451000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60388000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	849000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	835000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	7134000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16931000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14909000
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	3326000
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2794000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2593000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4315000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2521000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2764000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	49805000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	86005000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6141000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7325000
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13372000
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13946000
CY2023Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	4257000
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	3976000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17782000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21005000
CY2023Q4	us-gaap	Goodwill Goodwill	187703000
CY2022Q4	us-gaap	Goodwill Goodwill	194362000
CY2023Q4	note	Intangible Assets Net Excluding Goodwill Customer Relationships IntangibleAssetsNetExcludingGoodwillCustomerRelationships	53917000
CY2022Q4	note	Intangible Assets Net Excluding Goodwill Customer Relationships IntangibleAssetsNetExcludingGoodwillCustomerRelationships	56348000
CY2023Q4	note	Indefinite Lived Intangible Assets Net Excluding Goodwill Database Net IndefiniteLivedIntangibleAssetsNetExcludingGoodwillDatabaseNet	18838000
CY2022Q4	note	Indefinite Lived Intangible Assets Net Excluding Goodwill Database Net IndefiniteLivedIntangibleAssetsNetExcludingGoodwillDatabaseNet	21020000
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	18113000
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	28728000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	633000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	442000
CY2023Q4	us-gaap	Assets Assets	370561000
CY2022Q4	us-gaap	Assets Assets	433157000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	105000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	68000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12909000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13739000
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	43530000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	35569000
CY2023Q4	note	Customer Deposits Liability Current CustomerDepositsLiabilityCurrent	3032000
CY2022Q4	note	Customer Deposits Liability Current CustomerDepositsLiabilityCurrent	3252000
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	130000
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	696000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3066000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6709000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2878000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2079000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	65650000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	62112000
CY2023Q4	note	Long Term Debt Net Of Current Maturities LongTermDebtNetOfCurrentMaturities	222310000
CY2022Q4	note	Long Term Debt Net Of Current Maturities LongTermDebtNetOfCurrentMaturities	161980000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2178000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	714000
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	875000
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	918000
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	883000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26162000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29110000
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	4761000
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	18892000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5166000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13858000
CY2023Q4	us-gaap	Liabilities Liabilities	327102000
CY2022Q4	us-gaap	Liabilities Liabilities	288467000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	860485000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	846205000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-622000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-785000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-816416000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-700743000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	43459000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	144690000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	370561000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	433157000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	132645000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113765000
CY2023	note	Cost Of Revenues CostOfRevenues	40251000
CY2022	note	Cost Of Revenues CostOfRevenues	31937000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18186000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20736000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	45722000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	42678000
CY2023	note	Editorial Expense EditorialExpense	17869000
CY2022	note	Editorial Expense EditorialExpense	15956000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	65550000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	77801000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11509000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10451000
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	32064000
CY2023	note	Transaction Costs Gains TransactionCostsGains	-767000
CY2022	note	Transaction Costs Gains TransactionCostsGains	2395000
CY2023	us-gaap	Operating Expenses OperatingExpenses	230384000
CY2022	us-gaap	Operating Expenses OperatingExpenses	201954000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-97739000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-88189000
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	29940000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	95741000
CY2023	note	Change In Fair Value Of Financial Instruments ChangeInFairValueOfFinancialInstruments	-15983000
CY2022	note	Change In Fair Value Of Financial Instruments ChangeInFairValueOfFinancialInstruments	-12747000
CY2022	note	Gains Losses On Extinguishment Of Paycheck Protection Program Loan GainsLossesOnExtinguishmentOfPaycheckProtectionProgramLoan	7667000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-45250000
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-3474000
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-11700000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-68000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1045000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-115238000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-221511000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	223000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3254000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-115461000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-218257000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	163000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-154000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-115298000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-218411000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-115461000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-218257000
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	26570000
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-115461000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-115461000
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-244827000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-244827000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.68
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.68
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131400109
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131400109
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66513704
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66513704
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-482045000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	-26570000
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	88000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38090000
CY2022	note	Withholding Taxes On Net Share Settlement Of Stock Based Compensation And Option Exercises WithholdingTaxesOnNetShareSettlementOfStockBasedCompensationAndOptionExercises	2670000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-218257000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-154000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	144690000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	366000
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-21410000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27057000
CY2023	note	Withholding Taxes On Net Share Settlement Of Stock Based Compensation And Option Exercises WithholdingTaxesOnNetShareSettlementOfStockBasedCompensationAndOptionExercises	1872000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-115461000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	163000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	43459000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-115461000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-218257000
CY2023	us-gaap	Depreciation Depreciation	1348000
CY2022	us-gaap	Depreciation Depreciation	1238000
CY2023	note	Amortization Of Intangible Assets And Capitalized Software Development Costs AmortizationOfIntangibleAssetsAndCapitalizedSoftwareDevelopmentCosts	27369000
CY2022	note	Amortization Of Intangible Assets And Capitalized Software Development Costs AmortizationOfIntangibleAssetsAndCapitalizedSoftwareDevelopmentCosts	19545000
CY2023	note	Amortization Of Deferred Costs To Obtain Revenue Contracts AmortizationOfDeferredCostsToObtainRevenueContracts	3617000
CY2022	note	Amortization Of Deferred Costs To Obtain Revenue Contracts AmortizationOfDeferredCostsToObtainRevenueContracts	2786000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	32064000
CY2023	note	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	3264000
CY2022	note	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	6614000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	27057000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	38047000
CY2023	note	Non Cash Earnout Benefit Expense NonCashEarnoutBenefitExpense	-530000
CY2022	note	Non Cash Earnout Benefit Expense NonCashEarnoutBenefitExpense	-238000
CY2023	note	Gain Loss On Settlement GainLossOnSettlement	-3474000
CY2022	note	Gain Loss On Settlement GainLossOnSettlement	-11700000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	423000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	142000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2043000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2121000
CY2023	note	Change In Fair Value Of Financial Instruments ChangeInFairValueOfFinancialInstruments	-15983000
CY2022	note	Change In Fair Value Of Financial Instruments ChangeInFairValueOfFinancialInstruments	-12747000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	72000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3076000
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	6060000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	10958000
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	32000
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	260000
CY2023	note	Non Cash Interest Expense NonCashInterestExpense	3919000
CY2022	note	Non Cash Interest Expense NonCashInterestExpense	52044000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-45250000
CY2022	note	Gains Losses On Extinguishment Of Paycheck Protection Program Loan GainsLossesOnExtinguishmentOfPaycheckProtectionProgramLoan	7667000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	287000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3941000
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-3421000
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-422000
CY2023	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	4443000
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	4129000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	180000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	395000
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-6426000
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2113000
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4123000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4780000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-198000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	93000
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	269000
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1938000
CY2023	note	Increase Decrease In Contingent Liabilities From Acquisitions Current Portion IncreaseDecreaseInContingentLiabilitiesFromAcquisitionsCurrentPortion	-39000
CY2022	note	Increase Decrease In Contingent Liabilities From Acquisitions Current Portion IncreaseDecreaseInContingentLiabilitiesFromAcquisitionsCurrentPortion	-1567000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6626000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8589000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	210000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	274000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35494000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-72625000
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7938000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11367000
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5010000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-1125000
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7369000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20317000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10242000
CY2022	note	Proceeds From Business Combination Net Of Transaction Costs ProceedsFromBusinessCombinationNetOfTransactionCosts	175000000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-45242000
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	11500000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	166014000
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	107000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	189105000
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4498000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	684000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	453000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	88000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12077000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	111530000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-189000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-449000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-43923000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28214000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61223000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33009000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17300000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61223000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	34947000
CY2022	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	26570000
CY2023	note	Issuance Of Common Stock In Connection With Business Acquisitions IssuanceOfCommonStockInConnectionWithBusinessAcquisitions	9539000
CY2022	note	Issuance Of Common Stock In Connection With Business Acquisitions IssuanceOfCommonStockInConnectionWithBusinessAcquisitions	8590000
CY2023	note	Warrants Issued In Conjunction With Long Term Debt Issuance WarrantsIssuedInConjunctionWithLongTermDebtIssuance	178000
CY2022	note	Warrants Issued In Conjunction With Long Term Debt Issuance WarrantsIssuedInConjunctionWithLongTermDebtIssuance	436000
CY2022	note	Noncash Transaction Issuance Of Common Stock Upon Exercise Of Public Warrants NoncashTransactionIssuanceOfCommonStockUponExerciseOfPublicWarrants	265000
CY2022	note	Fees Payable To Debt Holders Settled Through Increase Of Debt Principal FeesPayableToDebtHoldersSettledThroughIncreaseOfDebtPrincipal	100000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	161000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	20679000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	35157000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	55000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	55000
CY2023	note	Description Of Business Policy Policy Textblock DescriptionOfBusinessPolicyPolicyTextblock	<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Description of Business</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">FiscalNote Holdings, Inc. (“FiscalNote,” or the “Company”) is a leading technology provider of global policy and market intelligence. It delivers critical, actionable legal and policy insights in a rapidly evolving political and regulatory and macroeconomic environment. By combining artificial intelligence (AI) technology, other technologies with analytics, workflow tools, and expert peer insights, FiscalNote empowers customers to manage policy, address regulatory developments, and mitigate global risk. FiscalNote ingests unstructured legislative and regulatory data, and employs AI and data science to deliver structured, relevant and actionable information in order to facilitate key operational and strategic decisions by global enterprises, midsized and smaller businesses, government institutions, trade groups, and nonprofits. FiscalNote delivers that intelligence through its suite of public policy and issues management products. The Company is headquartered in Washington, D.C.</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">On July 29, 2022 (the “Closing Date”), the Company consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2021, and as amended on May 9, 2022, (the “Merger Agreement”), by and among FiscalNote Holdings, Inc., a Delaware corporation (“Old FiscalNote”), Duddell Street Acquisition Corp., a Cayman Islands exempted company (“DSAC”), and Grassroots Merger Sub, Inc., a Delaware Corporation and a wholly owned direct subsidiary of DSAC (“Merger Sub” and, together with DSAC, the “DSAC Parties”). Pursuant to these transactions, Merger Sub merged with and into Old FiscalNote, with Old FiscalNote becoming a wholly owned subsidiary of DSAC (the “Business Combination” and, collectively with the other transactions described in the Business Combination Agreement, the “Transactions”). In connection with the closing of the Transactions (the “Closing”), DSAC domesticated and continued as a Delaware corporation under the name of “FiscalNote Holdings, Inc.” (“New FiscalNote”). Unless the context otherwise requires, references in these notes to the financial statements to the “Company,” “FiscalNote,” “we,” “us,” or “our” refer to the business of Old FiscalNote, which became the business of New FiscalNote and its subsidiaries following the Closing.</span></p>
CY2023	note	Liquidity Policy Policy Textblock LiquidityPolicyPolicyTextblock	<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Historically the Company’s cash flows from operations have not been sufficient to fund its current operating model and the Company funded operations through raising equity and debt. The Company's ability to maintain its minimum cash requirement, fund its future cash interest requirements under its senior term loan and fund its operations depend in part on general economic, financial, competitive, legislative, regulatory and other conditions that may be beyond the Company's control. Accordingly, the Company continues to closely monitor expenses to assess whether any immediate, or long-term changes, are necessary to maintain compliance with its financial covenants.</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company’s cash, cash equivalents, restricted cash, and short-term investments were </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">24,434</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> as of December 31, 2023, compared with </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">61,223</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> as of December 31, 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. Further, the Company had negative working capital (excluding cash, restricted cash, and short-term investments) of $</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">40,279</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">37,330</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> at </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023 and December 31, 2022, respectively, and had an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">816,416</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">700,743</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> as of December 31, 2023 and December 31, 2022, respectively, and has incurred net losses of </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">115,461</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">218,257</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> for the years ended December 31, 2023 and 2022, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Management expects that significant on-going operating and capital expenditures will be necessary to continue to implement the Company’s business plan of entering new markets, future acquisitions, and infrastructure and product development.</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">In addition, as disclosed in Note 9, “Debt”, the Company is subject to certain financial covenants. The Company’s ability to maintain compliance with these financial covenants are based on the Company’s current expectations regarding continued growth in revenues, collections, cost structure, current cash burn rate and other operating assumptions.</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company believes our cash on hand at December 31, 2023, net proceeds from the sale of Board.org (see Note 19, Subsequent Events ), proceeds from our expected product sales, and available borrowings under our Senior Term Loan for certain acquisition activity, will be sufficient to meet our obligations and our required covenants for at least the next twelve months from the date of this filing.</span></p>
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	24434000
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	61223000
CY2023Q4	note	Working Capital Deficit WorkingCapitalDeficit	40279000
CY2022Q4	note	Working Capital Deficit WorkingCapitalDeficit	37330000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-816416000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-700743000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-115461000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-218257000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions in the Company’s consolidated financial statements and notes thereto. Significant estimates and assumptions made by management include the determination of:</span></p><div style="margin-left:4%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">revenue recognition;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the average period of benefit associated with costs capitalized to obtain revenue contracts;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the fair value of assets acquired and liabilities assumed for business combinations;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the useful lives of intangible assets;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">capitalization of software development costs;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">valuation of financial instruments;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">impairment of goodwill and long-lived assets;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the fair value of certain stock awards issued;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the fair value of certain consideration issued as part of business combinations;</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the recognition, measurement, and valuation of current and deferred income taxes and uncertain tax positions; and</span></div></div><div style="margin-left:4%;display:flex;margin-top:4pt;justify-content:flex-start;align-items:baseline;margin-bottom:9pt;min-width:4%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.166666666666667%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">the incremental borrowing rate used to calculate lease balances.</span></div></div><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, which forms the basis for making judgments about the carrying values of assets and liabilities.</span></p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:10pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Risks</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. The Company generally maintains its cash and cash equivalents with various nationally recognized financial institutions. The Company’s cash and cash equivalents at times exceed amounts guaranteed by the Federal Deposit Insurance Corporation.</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company does not require collateral for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the consolidated statements of operations, included in sales and marketing expense, up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to deferred revenue on the consolidated balance sheets. Receivables are written off and charged against the recorded allowance when the Company has exhausted collection efforts without success.</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">No single customer accounted for more than </span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">% of the Company's accounts receivable balance as of </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023 and December 31, 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. Revenue derived from the U.S. Federal Government was </span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">% of revenue for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023 and December 31, 2022. As of December 31, 2023 and December 31, 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, assets located in the United States were approximately </span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">92</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">percent of total assets.</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">No vendors and two vendors individually accounted for more than </span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">% of the Company’s accounts payable as of </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023 and December 31, 2022, respectively. During the years ended December 31, 2023 and 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, no vendor and one vendor represented more than </span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">% of the total purchases made.</span></p>
CY2023	note	Costs Capitalized To Obtain Revenue Contracts Policy Policy Textblock CostsCapitalizedToObtainRevenueContractsPolicyPolicyTextblock	<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Costs Capitalized to Obtain Revenue Contracts</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company capitalizes incremental costs of obtaining a contract. Certain sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions incurred for obtaining new contracts are deferred and then amortized as selling and marketing expenses on a straight-line basis over a period of benefit that the Company has determined to be approximately </span><span style="font-size:11pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">four years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The four-year amortization period was determined based on several factors, including the nature of the technology and proprietary data underlying the services being purchased, customer contract renewal rates and industry competition. The Company updates its estimate of the period of benefit periodically and whenever events or circumstances indicate that the period of benefit could change significantly. Such changes, if any, are accounted for prospectively as a change in estimate. </span><span style="font-size:11pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company has elected to use a practical expedient to expense commissions for renewal contracts when the renewal period is 12 months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. The Company does not have material costs to fulfill contracts with customers.</span></p>
CY2023Q4	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2023	us-gaap	Revenue Practical Expedient Remaining Performance Obligation Description RevenuePracticalExpedientRemainingPerformanceObligationDescription	The Company has elected to use a practical expedient to expense commissions for renewal contracts when the renewal period is 12 months or less
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	109151000
CY2023Q4	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6223000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	25841000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	0
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0
CY2023	note	Related Party Transactions Policy Policy Textblock RelatedPartyTransactionsPolicyPolicyTextblock	<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Related Party Transactions</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">From time to time the Company has entered into related party transactions with certain of the Company's directors and officers. These transactions have historically included term loans, convertible debt, and convertible preferred stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023	note	Recent Accounting Pronouncements Not Yet Effective Policy Policy Textblock RecentAccountingPronouncementsNotYetEffectivePolicyPolicyTextblock	<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements Not Yet Effective</span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07 </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Segment Reporting (Topic 280)</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> guidance for segment reporting. The new guidance amends segment reporting to include significant segment expenses. The guidance will be effective for the Company's year beginning January 1, 2024. The Company does not expect that this guidance will have a significant impact on our disclosures.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company has evaluated all issued Accounting Standards Updates and believes the adoption of these standards will not have a material impact on its consolidated statements of operations and comprehensive loss, balance sheets, or cash flows.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The amendments in the ASU enhance income tax disclosures, primarily through standardization, disaggregation of rate reconciliation categories, and income taxes paid by jurisdiction. ASU 2023-09 is effective for fiscal</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">years </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">beginning after December 15, 2024, with early adoption allowed. We are currently evaluating the impact of adoption on our financial disclosures.</span></p>
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	132645000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113765000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	132645000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113765000
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1183000
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1464000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	30097000
CY2022	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	1055000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-29351000
CY2022	note	Contract With Customer Liability New Deferrals Net Of Amounts Recognized ContractWithCustomerLiabilityNewDeferralsNetOfAmountsRecognized	35139000
CY2022	note	Contract With Customer Liability Increase Decrease For Effects Of Foreign Currency ContractWithCustomerLiabilityIncreaseDecreaseForEffectsOfForeignCurrency	-453000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	36487000
CY2023	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	3933000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-35598000
CY2023	note	Contract With Customer Liability New Deferrals Net Of Amounts Recognized ContractWithCustomerLiabilityNewDeferralsNetOfAmountsRecognized	39220000
CY2023	note	Contract With Customer Liability Increase Decrease For Effects Of Foreign Currency ContractWithCustomerLiabilityIncreaseDecreaseForEffectsOfForeignCurrency	363000
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	44405000
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	4421000
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	4081000
CY2022	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2023	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	6138000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	9769000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	841000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	518000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	550000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1236000
CY2023	us-gaap	Lease Cost LeaseCost	7529000
CY2022	us-gaap	Lease Cost LeaseCost	11523000
CY2023	us-gaap	Sublease Income SubleaseIncome	1442000
CY2022	us-gaap	Sublease Income SubleaseIncome	5350000
CY2022Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	378000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5402000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5183000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5298000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5288000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5163000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13004000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	39338000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10110000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	29228000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	9481000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	11805000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	272000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2074000
CY2022Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	378000
CY2022Q1	note	Reduction In Operating Lease Asset ReductionInOperatingLeaseAsset	378000
CY2021	note	Payment Of Sublease Termination Fee PaymentOfSubleaseTerminationFee	1682000
CY2023Q1	note	Sublease Termination Fee Payable SubleaseTerminationFeePayable	1682000
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-03-31
CY2017Q4	us-gaap	Incentive To Lessee IncentiveToLessee	750000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12458000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12295000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6317000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4970000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6141000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7325000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	171789000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	76190000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-4731000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	90868000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	161595000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	55499000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	106096000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	13364000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	11771000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	11481000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	11069000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9992000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	33191000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	90868000
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	27659000
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	12795000
CY2023	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	-1492000
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13372000
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	19815000
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	5869000
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13946000
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	424000
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	740000
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	6918000
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4064000
CY2023Q4	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6223000
CY2021Q4	us-gaap	Goodwill Goodwill	188768000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5794000
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-200000
CY2022Q4	us-gaap	Goodwill Goodwill	194362000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	18535000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	25841000
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	647000
CY2023Q4	us-gaap	Goodwill Goodwill	187703000
CY2023Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	20004000
CY2023	us-gaap	Reporting Unit Zero Or Negative Carrying Amount Name ReportingUnitZeroOrNegativeCarryingAmountName	PPIM
CY2023Q4	note	Gross Long Term Debt GrossLongTermDebt	225513000
CY2022Q4	note	Gross Long Term Debt GrossLongTermDebt	164291000
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3098000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2243000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	222415000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	162048000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	105000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	68000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	222310000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	161980000
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	236032000
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	182482000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	105000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	30340000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	39000000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	110111000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	45957000
CY2023Q4	note	Gross Long Term Debt GrossLongTermDebt	225513000
CY2023	note	Shares Authorized SharesAuthorized	1809000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1803000
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1391000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1181000
CY2023	note	Non Capitalizable Business Combination Costs NonCapitalizableBusinessCombinationCosts	415000
CY2022	note	Non Capitalizable Business Combination Costs NonCapitalizableBusinessCombinationCosts	2993000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2043000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2121000
CY2023	note	Transaction Cost Related To Contingent Compensation Benefit Expense TransactionCostRelatedToContingentCompensationBenefitExpense	530000
CY2022	note	Transaction Cost Related To Contingent Compensation Benefit Expense TransactionCostRelatedToContingentCompensationBenefitExpense	-342000
CY2023	note	Transaction Costs Gains TransactionCostsGains	-767000
CY2022	note	Transaction Costs Gains TransactionCostsGains	2395000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-115461000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-218257000
CY2022	note	Deemed Dividend Change In Redemption Value Of Preferred Stock DeemedDividendChangeInRedemptionValueOfPreferredStock	26570000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-115461000
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-115461000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-244827000
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-244827000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131400109
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131400109
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66513704
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66513704
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.68
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.68
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35029935
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30534627
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	80000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	7000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	55000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-75000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	16000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-110000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	151000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-178000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9882000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-32725000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2690000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-12632000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3415000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2949000
CY2023	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	16059000
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	45230000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	72000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3076000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	223000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3254000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.005
CY2023	note	Effective Income Tax Rate Reconciliation Effects Of Rate Other Than Statutory EffectiveIncomeTaxRateReconciliationEffectsOfRateOtherThanStatutory	-0.005
CY2022	note	Effective Income Tax Rate Reconciliation Effects Of Rate Other Than Statutory EffectiveIncomeTaxRateReconciliationEffectsOfRateOtherThanStatutory	-0.002
CY2023	note	Effective Income Tax Rate Reconciliation Interest Disallowance EffectiveIncomeTaxRateReconciliationInterestDisallowance	-0.002
CY2022	note	Effective Income Tax Rate Reconciliation Interest Disallowance EffectiveIncomeTaxRateReconciliationInterestDisallowance	-0.005
CY2023	note	Effective Income Tax Rate Reconciliation Warrant Revaluation EffectiveIncomeTaxRateReconciliationWarrantRevaluation	0.026
CY2022	note	Effective Income Tax Rate Reconciliation Warrant Revaluation EffectiveIncomeTaxRateReconciliationWarrantRevaluation	0.015
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.024
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.047
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2023	note	Effective Income Tax Rate Reconciliation Non Deductible Expense From Recapitalization EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseFromRecapitalization	-0.029
CY2022	note	Effective Income Tax Rate Reconciliation Non Deductible Expense From Recapitalization EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseFromRecapitalization	-0.044
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.122
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.165
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.001
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.002
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.015
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7341000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6389000
CY2023Q4	note	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	33161000
CY2022Q4	note	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	27686000
CY2023Q4	note	Deferred Tax Assetsdisallowed Original Issue Discount Interest DeferredTaxAssetsdisallowedOriginalIssueDiscountInterest	1527000
CY2022Q4	note	Deferred Tax Assetsdisallowed Original Issue Discount Interest DeferredTaxAssetsdisallowedOriginalIssueDiscountInterest	1092000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	104000
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7143000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	6378000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	878000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	3855000
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	8541000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5197000
CY2023Q4	note	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	7375000
CY2022Q4	note	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	9110000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	31682000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	30966000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	8559000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	8202000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	7876000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	4563000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	898000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	782000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	114981000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	104324000
CY2023Q4	note	Deferred Tax Liabilities Basis Difference In Fixed Assets DeferredTaxLiabilitiesBasisDifferenceInFixedAssets	1505000
CY2022Q4	note	Deferred Tax Liabilities Basis Difference In Fixed Assets DeferredTaxLiabilitiesBasisDifferenceInFixedAssets	1772000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	20931000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	23584000
CY2023Q4	note	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	-4362000
CY2022Q4	note	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	-5158000
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2819000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3010000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	29617000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	33524000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	87542000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71514000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2178000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	714000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16028000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	40605000
CY2023	note	Capitalization Of Research And Development Expense CapitalizationOfResearchAndDevelopmentExpense	180000
CY2022	note	Capitalization Of Research And Development Expense CapitalizationOfResearchAndDevelopmentExpense	719000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	639000
CY2022	note	Unrecognized Deferred Tax Liabilities UnrecognizedDeferredTaxLiabilities	89000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	639000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	728000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	89000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	639000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	639000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	639000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	639000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	80000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	72000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	96000
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	150662000
CY2022Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	2660
CY2023	note	Earned Cash Contingent Compensation Transferred From Level Three To Level One EarnedCashContingentCompensationTransferredFromLevelThreeToLevelOne	1267000
CY2023	note	Earned Cash Contingent Compensation Other Transfer Of Assets And Liabilities Between Levels EarnedCashContingentCompensationOtherTransferOfAssetsAndLiabilitiesBetweenLevels	0
CY2022	note	Earned Cash Contingent Compensation Other Transfer Of Assets And Liabilities Between Levels EarnedCashContingentCompensationOtherTransferOfAssetsAndLiabilitiesBetweenLevels	0
CY2023	dei	Auditor Firm AuditorFirmId	49

Files In Submission

Name	View Source	Status
0000950170-24-031826-index-headers.html	Edgar Link	pending
0000950170-24-031826-index.html	Edgar Link	pending
0000950170-24-031826.txt	Edgar Link	pending
0000950170-24-031826-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img139692345_0.jpg	Edgar Link	pending
img145191857_0.jpg	Edgar Link	pending
img50132484_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
note-20231231.htm	Edgar Link	pending
note-20231231.xsd	Edgar Link	pending
note-ex10_10.htm	Edgar Link	pending
note-ex21_1.htm	Edgar Link	pending
note-ex31_1.htm	Edgar Link	pending
note-ex31_2.htm	Edgar Link	pending
note-ex32.htm	Edgar Link	pending
note-ex97_1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
note-20231231_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NOTE
FiscalNote Holdings, Inc. Stock $note

2023 Q4 Form 10-K Financial Statement

#000095017024031826 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NOTE FiscalNote Holdings, Inc. Stock $note

2023 Q4 Form 10-K Financial Statement

#000095017024031826 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NOTE
FiscalNote Holdings, Inc. Stock $note